MONKASTA

This brand name is authorized in Germany, Estonia, Spain, Croatia, Italy, Lithuania, Malta, Poland, Romania

Active ingredients

The drug MONKASTA contains one active pharmaceutical ingredient (API):

1 Montelukast
UNII U1O3J18SFL - MONTELUKAST SODIUM

Montelukast is an orally active compound which binds with high affinity and selectivity to the CysLT1 receptor. Τhe CysLT type-1 (CysLT1) receptor is found in the human airway (including airway smooth muscle cells and airway macrophages) and on other pro-inflammatory cells (including eosinophils and certain myeloid stem cells). CysLTs have been correlated with the pathophysiology of asthma and allergic rhinitis.

Read about Montelukast

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
MONKASTA Film-coated tablet Medicines Authority (MT) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
R03DC03 Montelukast R Respiratory system → R03 Drugs for obstructive airway diseases → R03D Other systemic drugs for obstructive airway diseases → R03DC Leukotriene receptor antagonists
Discover more medicines within R03DC03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: DE Bundesinstitut für Arzneimittel und Medizinprodukte Identifier(s): 09765017, 09765023, 09765046
Country: EE Ravimiamet Identifier(s): 1289673, 1289684, 1289695, 1289707, 1289718, 1289729, 1289741, 1289752, 1289763, 1289774, 1289785, 1289796, 1289808, 1289819, 1289820, 1289831, 1289842, 1289864, 1289875, 1289909, 1289910, 1289921, 1289932, 1289943, 1289954, 1289965, 1289976, 1289987, 1289998, 1290002, 1290013, 1290024, 1290035, 1290046, 1290057, 1290068, 1290079, 1290080, 1355532, 1769036, 1769047, 1769058, 1769069, 1769070, 1769081
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 72930, 72931, 72932
Country: HR Agencija za lijekove i medicinske proizvode Identifier(s): HR-H-054532530, HR-H-715082312, HR-H-823027772
Country: IT Agenzia del Farmaco Identifier(s): 040398051, 040398202, 040398354
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1004931, 1004932, 1004954, 1025137, 1025138, 1025139, 1033663, 1033664, 1033665, 1033666, 1033667, 1033670, 1033671, 1033672, 1033673, 1033674, 1033675, 1033676, 1033677, 1033679, 1033680, 1033681, 1033682, 1033683, 1033684, 1033685, 1033686, 1033687, 1033688, 1033689, 1033690, 1033691, 1034544, 1034545, 1034546, 1034547, 1034548, 1034549, 1034550, 1034551, 1034552, 1034553, 1034554, 1034555, 1034556, 1089495
Country: MT Medicines Authority Identifier(s): MA982/01002, PI1438/05602A, PI908/22601A
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100198921, 100198967, 100201400
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W56684001, W56684002, W56684003, W56684004, W56684005, W56684006, W56684007, W56684008, W56684009, W56684010, W56684011, W56684012, W56684013, W56684014, W56684015, W56685001, W56685002, W56685003, W56685004, W56685005, W56685006, W56685007, W56685008, W56685009, W56685010, W56685011, W56685012, W56685013, W56685014, W56685015, W56686001, W56686002, W56686003, W56686004, W56686005, W56686006, W56686007, W56686008, W56686009, W56686010, W56686011, W56686012, W56686013, W56686014, W56686015

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.